Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POP-I perioperative anaemia treatment study after emergency surgery
ISRCTN24330080Phase 4Recruiting
- Sponsor
- Nottingham Clinical Trials Unit
- Start
- Aug 2023
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, open-label trial of ferric derisomaltose and darbepoetin alfa in anaemia (3 arms), sponsored by Nottingham Clinical Trials Unit. Primary endpoint: Days at home at 30 days. Started Aug 2023; status: recruiting.
02
Drugs
ferric derisomaltosedarbepoetin alfa
03
Conditions
anaemia
Beyond the preview
Go deeper on ISRCTN24330080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN24330080.